NADPH (tetracyclohexanamine)
NADPH (tetracyclohexanamine) structure
|
Common Name | NADPH (tetracyclohexanamine) | ||
|---|---|---|---|---|
| CAS Number | 100929-71-3 | Molecular Weight | 1142.12000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C45H82N11O17P3 | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
Use of NADPH (tetracyclohexanamine)NADPH tetra cyclohexanamine is a ubiquitous cofactor and biological reducing agent. |
| Name | [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate,cyclohexanamine |
|---|---|
| Synonym | More Synonyms |
| Description | NADPH tetra cyclohexanamine is a ubiquitous cofactor and biological reducing agent. |
|---|---|
| Related Catalog |
| Molecular Formula | C45H82N11O17P3 |
|---|---|
| Molecular Weight | 1142.12000 |
| Exact Mass | 1141.51000 |
| PSA | 497.66000 |
| LogP | 6.56240 |
| Storage condition | -20℃ |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.
Nat. Rev. Drug Discov. 10 , 453-471, (2011) NADPH oxidases are a family of enzymes that generate reactive oxygen species (ROS). The NOX1 (NADPH oxidase 1) and NOX2 oxidases are the major sources of ROS in the artery wall in conditions such as h... |
|
|
The role of free radical generation in increasing cerebrovascular permeability.
Free Radic. Biol. Med. 51 , 967-977, (2011) The brain endothelium constitutes a barrier to the passive movement of substances from the blood into the cerebral microenvironment, and disruption of this barrier after a stroke or trauma has potenti... |
|
|
Alzheimer's disease and cholesterol: the fat connection.
Neurochem. Res. 32 , 739-750, (2007) Since the discovery of the significance of the cholesterol-carrying apolipoprotein E and cholesterolaemia as major risk factors for Alzheimer's Disease (AD) there has been a mounting interest in the r... |
| |A-NADPH |
| Triphosphopyridine nucleotide,reduced form |
| TPNH |
| |A-Nicotinamide adenine dinucleotide phosphate,reduced tetra(cyclohexylammonium) salt |
| NADPH |
| NADPH (tetracyclohexanamine) |